pubmed-article:10811677 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10811677 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:10811677 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
pubmed-article:10811677 | lifeskim:mentions | umls-concept:C0014582 | lld:lifeskim |
pubmed-article:10811677 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
pubmed-article:10811677 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
pubmed-article:10811677 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:10811677 | lifeskim:mentions | umls-concept:C1519249 | lld:lifeskim |
pubmed-article:10811677 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:10811677 | pubmed:dateCreated | 2000-6-15 | lld:pubmed |
pubmed-article:10811677 | pubmed:abstractText | Sequence-dependent clinical and pharmacokinetic interactions between paclitaxel and doxorubicin have been reported. Some data have shown an influence of paclitaxel on epirubicin metabolism, but no data are available about the effect of diverse sequences of these drugs. We investigated whether reversing the sequence of epirubicin and paclitaxel affects the pattern or degree of toxicity and pharmacokinetics. | lld:pubmed |
pubmed-article:10811677 | pubmed:language | eng | lld:pubmed |
pubmed-article:10811677 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10811677 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10811677 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10811677 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10811677 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10811677 | pubmed:month | May | lld:pubmed |
pubmed-article:10811677 | pubmed:issn | 0732-183X | lld:pubmed |
pubmed-article:10811677 | pubmed:author | pubmed-author:RossiLL | lld:pubmed |
pubmed-article:10811677 | pubmed:author | pubmed-author:VenturiniMM | lld:pubmed |
pubmed-article:10811677 | pubmed:author | pubmed-author:EspositoMM | lld:pubmed |
pubmed-article:10811677 | pubmed:author | pubmed-author:BertelliGG | lld:pubmed |
pubmed-article:10811677 | pubmed:author | pubmed-author:LunardiGG | lld:pubmed |
pubmed-article:10811677 | pubmed:author | pubmed-author:VialeMM | lld:pubmed |
pubmed-article:10811677 | pubmed:author | pubmed-author:VannozziM OMO | lld:pubmed |
pubmed-article:10811677 | pubmed:author | pubmed-author:Del MastroLL | lld:pubmed |
pubmed-article:10811677 | pubmed:author | pubmed-author:TolinoGG | lld:pubmed |
pubmed-article:10811677 | pubmed:author | pubmed-author:AngioliniCC | lld:pubmed |
pubmed-article:10811677 | pubmed:author | pubmed-author:StraneoMM | lld:pubmed |
pubmed-article:10811677 | pubmed:author | pubmed-author:NumicoGG | lld:pubmed |
pubmed-article:10811677 | pubmed:author | pubmed-author:PastroneII | lld:pubmed |
pubmed-article:10811677 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10811677 | pubmed:volume | 18 | lld:pubmed |
pubmed-article:10811677 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10811677 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10811677 | pubmed:pagination | 2116-25 | lld:pubmed |
pubmed-article:10811677 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:meshHeading | pubmed-meshheading:10811677... | lld:pubmed |
pubmed-article:10811677 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10811677 | pubmed:articleTitle | Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity. | lld:pubmed |
pubmed-article:10811677 | pubmed:affiliation | Department of Medical Oncology I and Pharmacotoxicology Laboratory, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. mventur@hp380.ist.unige.it | lld:pubmed |
pubmed-article:10811677 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10811677 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10811677 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10811677 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10811677 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10811677 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10811677 | lld:pubmed |